Clinical Trial Update: Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the pharmacokinetics of alitretinoin (9-cis-retinoic acid) in patients with hepatic disease, spanning Phase 1 and Phase 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Toctino (alitretinoin)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Hepatic Insufficiency | Phase 1, Phase 2 | Status: COMPLETED